Your browser doesn't support javascript.
COVlD-19 vaccine Distribution: Preparing for the Unexpected
Pharmaceutical Technology Europe ; 33(1):25-26, 2021.
Article Dans Anglais | ProQuest Central | ID: covidwho-20242753
ABSTRACT
In December 2020, two shipments of the vaccine experienced temperature excursions in which product was actually kept at overly cold temperatures (3). Urgent need to protect data One problem that vaccine developers and regulatory agencies need to address is the urgent need to protect data, says Nigel Thorpe, technology director with Secure Age, which specializes in enterprise data encryption using a public key infrastructure platform. For operators on the plant floor, the efforts required are fraught with potential error, especially during shift changes, says Jim Evans, director of Verista, Inc.'s vision, connectivity, and automation division. Raw materials The speed with which vaccines have been developed and are being distributed pose important questions centred around variability. If we're having a raw materials shortage when the vaccines haven't even been scaled up, what will happen when they get full approval?" he asks.
Mots clés
Collection: Bases de données des oragnisations internationales Base de données: ProQuest Central Les sujets: Vaccins langue: Anglais Revue: Pharmaceutical Technology Europe Année: 2021 Type de document: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Collection: Bases de données des oragnisations internationales Base de données: ProQuest Central Les sujets: Vaccins langue: Anglais Revue: Pharmaceutical Technology Europe Année: 2021 Type de document: Article